Exane Derivatives’s Qiagen QGEN Stock Holding History

Exane Derivatives’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$773K	Buy	15,692 +1,654	+12%	+$80.7K	0.44%	54
2022 Q1	$0	Sell	14,038 -12,884	-48%	-$665K	﹤0.01%	1075
2021 Q4	$0	Sell	26,922 -24,151	-47%	-$1.38M	﹤0.01%	944
2021 Q3	$1	Buy	51,073 +17,757	+53%	+$989K	﹤0.01%	1044
2021 Q2	$0	Sell	33,316 -3,560	-10%	-$184K	﹤0.01%	1077
2021 Q1	$1.09M	Sell	36,876 -3,367	-8%	-$185K	0.31%	74
2020 Q4	$1.25M	Sell	40,243 -30,585	-43%	-$1.63M	0.37%	56
2020 Q3	$2.09M	Buy	70,828 +57,405	+428%	+$2.98M	0.61%	37
2020 Q2	$380K	Buy	+13,423	New	+$601K	0.1%	174
2018 Q1	–	Sell	-3,814	Closed	-$134K	–	652
2017 Q4	$127K	Buy	+3,814	New	+$131K	0.02%	269
2017 Q3	–	Sell	-39,790	Closed	-$1.37M	–	630
2017 Q2	$1.4M	Sell	39,790 -38,431	-49%	-$1.3M	0.3%	78
2017 Q1	$2.41M	Buy	+78,221	New	+$2.41M	0.55%	59

Other funds holding QGEN

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Exane Derivatives's QGEN Position: Q2 2022 in Review

Exane Derivatives increased its Qiagen (QGEN) stake by 12% in Q2 2022, buying an estimated $80.7K and bringing the position to 15,692 shares worth $773K. The position accounts for 0.44% of the portfolio, ranked #54.

Exane Derivatives first reported a position in QGEN in Q1 2017 and has held it in 12 quarters since. The position peaked at $2.41M in Q1 2017. 288 funds tracked by Wall St. Rank hold QGEN as of Q2 2022.

Exane Derivatives held 15,692 shares of Qiagen worth $773K as of Q2 2022.
Exane Derivatives bought 1,654 Qiagen shares in Q2 2022, an estimated $80.7K.
Qiagen made up 0.44% of Exane Derivatives's portfolio in Q2 2022, its #54 holding.
Exane Derivatives first reported a position in Qiagen in Q1 2017 and has held it in 12 quarters since.
Exane Derivatives's Qiagen position peaked at $2.41M in Q1 2017.
288 funds tracked by Wall St. Rank held Qiagen as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.